Dublin, Oct. 29, 2018 (GLOBE NEWSWIRE) -- The "Biobanks Market Size, Share & Trends Analysis Report By Product (LIMS), By Service (Cold Chain), By Biospecimen Type, By Biobank Type (Virtual), By Application, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global biobanks market size is expected to reach USD 74.54 billion by 2025 at a 4.5% CAGR over the forecast period.
Growing need for sample collection to support and facilitate clinical trials for novel therapies, which are developed for treatment of chronic conditions, is anticipated to boost the market.
Different biospecimens stored at biobanks are witnessing significant demand owing to advancements in cell-based research activities. Rising demand from different end users has led to establishment of a substantial number of population-based and disease-based banks in recent years. Population-based banks are established to support precision medicine research initiatives, whereas disease-specific biobanks provide resources to research communities to enable a better understanding of disease etiology.
Furthermore, there has been a rapid increase in number of biobanks over the recent past, which can be attributed to perpetual developments in cell-based therapies, such as advent of stem cells and regenerative medicine. Thus, competition among biobanks is observed within for-profit biostorage entities that provide open access to researchers and hospitals. Increase in efforts undertaken by life science industries for collaboration with biobanks to support life science research programs is expected to further boost the market.
In addition, regional biobank networks are being established to enhance accessibility to biospecimens and promote international sharing of these samples. Few examples of such networks are BBMIR-ERIC, Asian Network of Research Resource Centers, and Asian Consortium for the Conservation and Sustainable Use of Microbial Resources.
Increase in number of clinical trials for new drug candidates has spurred demand for biobanking services. Major challenges in biobanking operations include sustainability, limited access, and information sharing. However, technology advancements aid in overcoming these hurdles. Owing to introduction of novel applications of stored cells and biospecimens in drug development, leading economies such as U.S. and U.K. are revising their regulatory policies and guidelines pertaining to biobanking operations.
Further key findings from the report suggest:
- Biobanking equipment held the dominant share by product in 2017. High cost of equipment, coupled with rapid increase in number of biobanks, is attributive to its leading revenue share
- The LIMS segment is projected to witness lucrative growth over the forecast period owing to rise in efforts undertaken for improvement of sample quality to suit international standards
- North America dominated the global market in 2017 owing to high demand for biosamples. This increase in demand is attributive to rapid advancement of genomics, bioinformatics, and translational research
- Asia Pacific is projected to exhibit the fastest growth due to rapid progress of Asian countries in healthcare, drug discovery, and scientific research
- Some of the major companies offering biobanking products are QIAGEN; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; and Merck KGaA. VMR International, Charles River, Lonza, Biovault, Thermo Fisher Scientific (Fisher BioServices), and Virgin Health Bank are among prominent companies engaged in offering biobanking services.
Key Topics Covered:
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 Internal database
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
Chapter 3 Biobanks Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Increased focus on precision medicine and genetic testing
3.1.1.2 Changes in biobanking operations
3.1.1.3 Expansion in global clinical trials
3.1.1.4 Growing industry and research collaborations
3.1.1.5 Technology advancement and automation
3.1.2 Market restraint analysis
3.1.2.1 Challenges in sharing biobanking data & limited access to biospecimens
3.1.2.2 Sustainability challenges for biobanks
3.1.2.3 Other Challenges in biobanking specimens for research
3.2 Penetration & Growth Prospect Mapping for Application, 2017
3.3 Regulatory Landscape
3.3.1 Regulatory Landscape, U.S
3.3.2 Regulatory Landscape, Canada
3.3.3 Regulatory Landscape, Europe
3.3.4 Regulatory Landscape, China
3.3.5 Regulatory Landscape, Japan
3.4 List of factors/Regulations /Nature Of Governments, By Country
3.4.1 List of Regulations, U.S.
3.4.2 List of Regulations, Europe
3.5 Biobanks Market - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter's
Chapter 4 Biobanks Market Categorization: Products Estimates & Trend Analysis
4.1 Global Biobanks Market: Products Movement Analysis, 2017 & 2025
4.2 Biobanking Equipment
4.2.1 Global biobanking equipment market, 2014 - 2025 (USD Million)
4.2.2 Temperature control systems
4.2.2.2 Freezers & refrigerators
4.2.2.3 Cryogenic storage systems
4.2.2.4 Thawing equipment
4.2.3 Incubators & centrifuges
4.2.4 Alarms & monitoring systems
4.2.5 Accessories & other equipment
4.3 Biobanking Consumables
4.4 Laboratory Information Management Systems (LIMS)
Chapter 5 Biobanks Market Categorization: Services Estimates & Trend Analysis
5.1 Global Biobanks Market: Services Movement Analysis, 2017 & 2025
5.2 Biobanking & Repository
5.3 Lab Processing
5.4 Qualification/ Validation
5.5 Cold Chain Logistics
5.6 Other Biobanking Services
Chapter 6 Biobanks Market Categorization: Biospecimen Types Estimates & Trend Analysis
6.1 Global Biobanks Market: Biospecimen Types Movement Analysis, 2017 & 2025
6.2 Human Tissues
6.3 Human Organs
6.4 Stem Cells
6.4.2 Adult stem cells
6.4.3 Embryonic stem cells
6.4.4 Induced Pluripotent Stem Cells (iPSCs)
6.4.5 Other Stem Cells
6.5 Other Biospecimens
Chapter 7 Biobanks Market Categorization: Biobank Types Estimates & Trend Analysis
7.1 Global Biobanks Market: Biobank Types Movement Analysis, 2017 & 2025
7.2 Physical/Real Biobanks
7.2.1 Global physical/real biobanks market, 2014 - 2025 (USD Million)
7.2.2 Tissue biobanks
7.2.3 Population based biobanks
7.2.4 Genetic (DNA/RNA) based biobanks
7.2.5 Disease based biobanks
7.3 Virtual Biobanks
Chapter 8 Biobanks Market Categorization: Application Estimates & Trend Analysis
8.1 Global Biobanks Market: Application Movement Analysis, 2017 & 2025
8.2 Therapeutics
8.3 Drug Discovery & Clinical Research
8.4 Clinical Diagnostics
8.5 Other Applications
Chapter 9 Biobanks Market Categorization: Regional Estimates & Trend Analysis, by Products, Services, Biospecimen Types, Biobank Types, & Applications
Chapter 10 Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Qiagen
- Hamilton Company
- VWR International, LLC.
- Tecan Trading AG.
- Danaher
- Becton, Dickinson and Company (BD)
- BioCision
- Taylor-Wharton
- Charles River
- Lonza
- STEMCELL Technologies Inc.
- Biovault
- PromoCell GmbH
- Virgin Health Bank
For more information about this report visit https://www.researchandmarkets.com/research/d9jx94/global_biobanks?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.